Clinical Trial Update: Preoperative Treatment of HR+/HER2+Breast Cancer With Pirotinib, Trastuzumab and AI Research [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update exploring preoperative treatment of HR+/HER2+ breast cancer with pirotinib, trastuzumab, and an AI-based therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trastuzumab (trastuzumab)
• pirotrinib

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN